Stanford University
Showing 12,631-12,640 of 37,018 Results
-
Preeti Hehmeyer
Executive Director, RegLab, Regulation, Evaluation, and Governance Lab
Current Role at StanfordManaging Director, California Policy Research Initiative (CAPRI)
Lecturer, Public Policy -
Shireen N. Heidari
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioShireen Heidari, MD is a palliative care and family medicine physician. She works as part of the inpatient palliative care consult team providing symptom management and support for patients and families facing any stage of a serious illness. Dr. Heidari is the program director for the Stanford University Hospice and Palliative Fellowship. She previously served as the clinical lead for the Stanford site of the PERIOP-PC Study, collaborating with the surgical department to evaluate the impact of early palliative care support for patients and family members preparing for major upper gastrointestinal cancer surgery.
Dr. Heidari is also a writer whose pieces about the importance of human connection, tough conversations, and stigma around healthcare workers seeking help for their mental health have been published in The New England Journal of Medicine, The Lancet Respiratory Medicine, CHEST, The Journal of Pain and Symptom Management, and the Intima. She hopes that by sharing her own story, she can continue being part of these conversations as we advocate for culture change in medicine and more sustainable practice.
Before moving to northern California, Dr. Heidari attended medical school at Boston University, completed her residency at UC San Diego where she served as chief resident, followed by palliative fellowship at UCLA. Outside of her clinical and mentorship work, she is likely writing creatively or outside with her husband chasing their dogs. She is currently writing her first fiction novel. -
Paul Heidenreich, MD
Professor of Medicine (Cardiovascular)
On Partial Leave from 05/01/2026 To 06/30/2026Current Research and Scholarly InterestsMy research interests include
1) The cost-effectiveness of new cardiovascular technologies.
Example: tests to screen asymptomatic patients for left ventricular systolic dysfunction.
2) Interventions to improve the quality of care of patients with heart disease. Examples: include clinical reminders and home monitoring.
3) Outcomes research using existing clinical and administrative datasets.
4) Use of echocardiography to predict prognosis (e.g. diastolic dysfunction).
